Infectologia Pediátrica
Crianças com infecção sintomática por SARS-CoV-2 têm carga viral similar e podem ser tão contagiosas quanto adultos sintomáticos.
14 Jun, 2021 | 11:21hEditorial: Implications of SARS-CoV-2 Viral Load in Children: Getting Back to School and Normal
Comentário no Twitter (fio – clique para saber mais)
In a new study in @JAMAPediatrics, we compared symptoms and viral load in children and adults with SARS-CoV-2. Those with symptoms had higher virus loads than those without. Importantly, within these groups – viral load was the same in children and adults. https://t.co/UgaFzvMNlg pic.twitter.com/cjpt2yqQ3R
— Helen Chu (@HelenChuMD) June 11, 2021
Estudo de coorte mostrou que a incidência de Síndrome Inflamatória Multissistêmica em Crianças (Multisystem Inflammatory Syndrome in Children – MIS-C) foi de 316 indivíduos em 1 milhão de infecções por SARS-CoV-2 em pessoas com menos de 21 anos. A incidência foi maior entre negros, hispânicos ou latinos, asiáticos e pessoas oriundas das ilhas do Pacífico.
14 Jun, 2021 | 11:20hComentário: MIS-C Incidence 316 Persons Per 1 Million SARS-CoV-2 Infections – HealthDay
Comentário no Twitter
About 1 in every 3,000 children who got COVID ended up with MIS-C. MIS-C incidence among Black persons and Hispanic or Latino persons was approximately 9x higher, and incidence among Asian or Pacific Islander persons was approximately 3x higher https://t.co/JTEsvgvFcz
— Daniel Griffin MD PhD (@DanielGriffinMD) June 12, 2021
CDC afirma que casos de inflamação cardíaca em pessoas de 16 a 24 anos depois da segunda dose da vacina contra Covid foram acima do esperado, mas, ainda assim, raros.
11 Jun, 2021 | 10:42hVer também: CDC plans “emergency meeting” on rare heart inflammation following COVID-19 vaccines – CBC News
Relacionado: Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men.
China vai vacinar crianças a partir de 3 anos de idade contra a COVID-19.
9 Jun, 2021 | 09:57hChina to offer COVID-19 vaccine to children as young as three – MedicalXpress
Ver também: Sinovac says its vaccine is safe for children as young as 3 – Associated Press
Em jovens, a COVID-19 causa mais complicações do que a gripe; as fatalidades são raras.
9 Jun, 2021 | 09:54hEstudo original: 30-Day Outcomes of Children and Adolescents With COVID-19: An International Experience – Pediatrics
Condições médicas subjacentes associadas à COVID-19 grave em crianças – Os principais fatores de risco para hospitalização foram doenças crônicas e complexas, diabetes tipo 1 e obesidade.
8 Jun, 2021 | 10:31hComentários: Underlying illness, respiratory infection raise risk for severe COVID in kids – CIDRAP E COVID-19 in Children—Not Just Little Adults – JAMA Network Open
Comentário no Twitter
This cross-sectional study found a higher risk of severe #COVID19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. https://t.co/ifq1Ao0HKS
— JAMA Network Open (@JAMANetworkOpen) June 7, 2021
OMS: A vacinação de crianças “não é uma grande prioridade” em meio à escassez de vacinas.
4 Jun, 2021 | 08:20hWHO: Vaccinating kids ‘not a high priority’ amid shortage – Associated Press
Relacionado: WHO: Wealthy nations urged to delay youth Covid vaccines, donate to solidarity scheme E Editorial: Vaccinating children against SARS-CoV-2 – “Hard to justify right now for most children in most countries”. E Opinion | American Kids Can Wait – “The U.S. should delay shots for children until global vaccine-manufacturing capacity significantly expands and the crisis in India subsides”. E Vaccinating children before poor morally wrong, Oxford scientist says – BBC
Estudo de coorte mostrou boa recuperação na maioria das crianças 6 meses após síndrome multissistêmica inflamatória pediátrica (pediatric inflammatory multisystem syndrome – PIMS-TS) associada ao SARS-CoV-2.
3 Jun, 2021 | 10:07hComentário: Most severe effects of MIS-C in children typically resolve within six months, new research suggests – CNN E Children who developed a rare inflammation disease after COVID-19 are mostly better after 6 months, but some still suffer fatigue and anxiety, a small UK study found – Insider E Most severe effects of PIMS-TS resolved at six months – HealthDay
Comentário no Twitter
New Research—A study of 46 patients with #PIMSTS found that most symptoms were resolved after 6 months, but fatigue, difficulty exercising, and emotional difficulties persisted in some childrenhttps://t.co/mHz3D8a11d #COVID19 @GreatOrmondSt @KarynMoshal pic.twitter.com/PJCxGGmJNo
— The Lancet Child & Adolescent Health (@LancetChildAdol) May 24, 2021
Israel relata ligação entre casos raros de inflamação cardíaca e vacinação contra COVID-19 em homens jovens.
2 Jun, 2021 | 10:26hIsrael reports link between rare cases of heart inflammation and COVID-19 vaccination in young men – Science (poucos artigos gratuitos por mês)
Comentário no Twitter
👇Paging @CDCgov and @US_FDA
“In a report submitted today to the Israeli Ministry of Health, they conclude that between one in 3000 and one in 6000 men ages 16 to 24 who received the vaccine developed the rare condition.” https://t.co/aoz2rkgdwO
— Ramin Farzaneh-Far MD (@rfsquared) June 1, 2021
Estudo randomizado: Para atingir a cura clínica em torno de 28 dias em crianças com bronquite bacteriana prolongada, um curso de 4 semanas de amoxicilina-clavulanato não é melhor do que um curso de 2 semanas.
31 Mai, 2021 | 12:03hComentário: Four weeks of antibiotics for kids’ chronic cough no better than 2, study finds – CIDRAP
Comentário no Twitter
NEW Research—4 weeks of amoxicillin–clavulanate for children with chronic wet cough and suspected PBB confers little advantage vs 2 weeks in achieving clinical cure by 28 days
RCT from Tom Ruffles & colleagues https://t.co/77w08dZ20z pic.twitter.com/LYgOeJbDX8
— The Lancet Respiratory Medicine (@LancetRespirMed) May 26, 2021